BLOG/🇺🇸United States··daily

US Executive Compensation Proxy SEC Filings — March 20, 2026

Executive Compensation Insights

50 high priority50 total filings analysed

Executive Summary

Across 50 DEF 14A proxy statements, a dominant theme is robust 2025 performance with 18 companies reporting YoY revenue growth averaging 10%+ (e.g., Ameriprise +6% rev/$18.2B, Goldman +9%/$58.3B, Inspire +14%/$912M, Eli Lilly $65.2B), strong EPS expansions (Goldman +27% to $51.32, Ameriprise +12% to $39.34), and margin improvements (Latham +320bps gross margins, Pentair +170bps adj ROS), though 6 showed declines like Avalon net income -76% YoY. Positive sentiment prevails in 22 filings (44%), mixed/neutral in 28, with no explicit insider selling but high ownership concentrations signaling alignment (e.g., Preformed Line 33% insiders). Capital allocation favors shareholders via dividend hikes (Ameriprise 21st consecutive +20% returns, Penske $182M buybacks/1.8% shares), buybacks, and LTIPs tied to CAGR targets. Portfolio-level trends highlight financials/healthcare outperformance vs industrials mixed results, with pay-for-performance evident (Cogent CEO 152% AWR target payout). AGMs cluster April 29-May 13, 2026 as key catalysts for comp votes, auditor ratifications, and equity plan amendments. Market implications: Buy dips in high-performers pre-vote, monitor pay scrutiny in decliners.

Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from March 19, 2026.

Investment Signals(12)

  • Adjusted EPS +12% YoY to $39.34, net rev +6% to $18.2B, AUMAA +11% to $1.7T, $3.4B shareholder returns +20% YoY, 21st consecutive dividend hike

  • Eli Lilly(BULLISH)

    Revenue $65.2B, reported EPS $22.95/non-GAAP $24.21, TSR +40% beating S&P/pharma peers, FDA approvals Kisunla/Omvoh, Zepbound superior 20.2% weight loss vs Wegovy 13.7%

  • Net rev +9% YoY to $58.3B (ex-Apple +11% to $60.5B), EPS +27% to $51.32, ROE +230bps to 15%, TSR +57%, acquisitions/partnerships

  • Net sales +7.4% YoY to $545.9M outperforming declining pool market, gross margins +320bps, Adj EBITDA $99.8M, acquisitions boosted margins

  • Revenue +14% YoY to $912M, strong gross/operating margins, 125k+ patients treated, new Inspire V launch

  • Revenue $31.8B, net income $938M, EPS $14.13, acquisitions +$1.6B ann rev, $182M buybacks (1.8% shares), dividend increases

  • Record HIV sales Biktarvy, Yeztugo launch, Trodelvy data, Arcellx acquisition, bulevirtide launch 2026, 7 HIV launches by 2033

  • Pentair(BULLISH)

    Adj operating income +10% YoY to $1.053B, adj EPS +14% to $4.92, FCF +8% to $748.4M, dividend +8.7% to $0.25

  • CEO pay -5% YoY to $255k, AWMS CEO -10% to $480k aligned with net income -76% YoY to $321k, no equity awards/expired options

  • Net income +56.1% YoY to $67.5M but total assets -2% to $6.97B, net loans -0.4%, overhead +6.3% to 2.36%

  • CEO pay +10% YoY to $7.2M but non-equity incentive -2% to $1.52M, COO pay -2% [MIXED/BEARISH]

  • CEO incentives 152% AWR target ($333.5k) but 79% GP target ($196.7k), base salaries +2.5% non-CEO

Risk Flags(9)

Opportunities(9)

  • EPS +12% YoY, ROE +60bps to 53.3%, adj margins +40bps, virtual AGM Apr 29 2026 say-on-pay likely passes

  • Zepbound superior data, orforglipron Ph3, Verve acquisition, $15.7B mfg investments, AGM May 4 2026 declassify board

  • Bulevirtide US launch 2026, 7 HIV products by 2033, Arcellx deal, strong HIV/oncology

  • +320bps gross margins despite market decline, fiberglass 76.5% sales +double-digit Florida, AGM Apr 30 add 3.4M shares to plan

  • +$1.6B ann rev from deals, strong cash flow/balance sheet, buybacks 1.8%, virtual AGM May 13

  • Rev +14% YoY, new CFO/CSGO, board declassify 2029, amend plan, AGM Apr 30

  • 13.5% ROE, NIW $61.9B, IIF $303.1B, ABVPS +42%, AGM Apr 23

  • Exceptional 2025 milestones, strong cash flow/balance sheet, virtual AGM Apr 30

  • Positive rev growth, Adj EBITDA/FCF improved, $67M new ACV, AI integration, AGM Apr 29 amend plan

Sector Themes(6)

  • Financials Outperformance(BULLISH SECTOR)

    8/15 financials (e.g., Ameriprise EPS +12%, Goldman +27%, MGIC 13.5% ROE +42% ABVPS, Heritage NI +56%) show rev/EPS growth avg +15% YoY vs industrials +5%, implies resilient deposits/wealth mgmt

  • Healthcare/Pharma Strength(BULLISH SECTOR)

    5/7 (Gilead record HIV, Lilly $65B rev/40% TSR, Inspire +14% rev) highlight pipeline/launches, avg rev growth 20%+ YoY, superior to S&P, watch 2026 launches

  • Industrials Mixed Margins(MIXED SECTOR)

    6/12 report margin gains (Latham +320bps, Pentair +170bps ROS) but flat sales (Pentair +2%), acquisitions drive (Penske +$1.6B rev), pool mkt decline offset

  • Governance/Pay Alignment(POSITIVE THEME)

    40/50 emphasize pay-for-performance (Cogent 152% payout, Avalon pay cuts w/ -76% NI), dividend hikes 5/50 (Ameriprise 21st consec, Pentair +8.7%), insider ownership high (Preformed 33%) signals conviction

  • Capital Returns Acceleration(BULLISH THEME)

    $3.4B Ameriprise +20% YoY, $182M Penske buybacks 1.8% shares, Latham Adj EBITDA $99.8M, implies strong FCF for buybacks/dividends vs reinvestment

  • Declines in Small Caps(BEARISH THEME)

    4/10 small/emerging (Avalon NI -76%, Heritage assets -2%) show pay cuts/expired options, reverse splits (Heritage Distilling), higher risk for turnarounds

Watch List(8)

Filing Analyses(50)
COGENT COMMUNICATIONS HOLDINGS, INC.DEF 14Amixedmateriality 7/10

20-03-2026

Cogent Communications Holdings, Inc.'s DEF 14A proxy statement details corporate governance practices, including full attendance by directors at the 2025 annual meeting and independence of all directors except CEO Dave Schaeffer. For 2025 executive compensation, base salaries for non-CEO Named Executive Officers increased 2.5%, CEO incentives achieved 152% of AWR CAGR target ($333,500 earned) but only 79% of GP CAGR target ($196,743), and sales commissions reached 92% for Mark Harris ($141,900) while at 77% for former CRO James Bubeck ($80,813). Significant long-term incentive grants were awarded, including up to 551,177 RSU shares for the CEO for 2026 service based on $12M notional value.

  • ·All directors except CEO determined independent per Nasdaq rules.
  • ·CEO 2025 LTIPs: 84,000 time-based RSUs and 96,000 performance-based RSUs (half EBITDA CAGR, half Free Cash Flow CAGR through 2027).
  • ·CEO 2026 LTIPs: 229,657 time-based RSUs vesting 2029 and 321,520 performance-based RSUs based on EBITDA CAGR through 2028.
  • ·Supplemental 100,000 time-based RSUs each to Chang, Harris, Weed vesting 2029 for Sprint acquisition retention.
  • ·Performance-based RSUs for Weed, Chang, Kilmer based on customer satisfaction or performance through 2028.
Primoris Services CorpDEF 14Apositivemateriality 7/10

20-03-2026

Primoris Services Corporation (NYSE: PRIM) has issued its 2026 Proxy Statement for the virtual Annual Meeting of Stockholders on April 30, 2026, at 9:00 a.m. CT, where shareholders will vote on electing eight directors, advisory approval of named executive officer compensation, and ratification of Baker Tilly US, LLP as independent auditors for the fiscal year ending December 31, 2026. The company describes 2025 as an exceptional year, achieving record milestones, accelerating strategic growth, generating strong cash flow, and strengthening its balance sheet. Chairman David L. King thanks retiring Board member John Schauerman for his long service.

  • ·Record date for shareholders entitled to vote: March 9, 2026
  • ·Virtual meeting registration deadline: April 24, 2026, 11:59 p.m. Central Time at www.proxydocs.com/PRIM
  • ·Principal executive offices: 2300 N. Field Street, Suite 1900, Dallas, Texas 75201
Metropolitan Bank Holding Corp.DEF 14Apositivemateriality 6/10

20-03-2026

The Board is actively overseeing AI integration, including appointing a Chief Artificial Intelligence Officer, establishing governance frameworks, and participating in executive education programs. As of December 31, 2025, employee headcount grew 10.2% YoY by 33 to 328 (326 full-time, 2 part-time), driven by business expansion and risk management strengthening, while gender diversity remained flat at 45% women and 55% men. The Board held 14 meetings in 2025 with an average attendance of 95%, and all directors attended the 2025 annual stockholder meeting.

  • ·No employees represented by collective bargaining agreement.
  • ·Board has four standing committees: Audit, Risk, CG&N, and Compensation (implied).
  • ·Audit Committee oversees independent auditors, financial statements, and internal audit function.
Claritev CorpDEF 14Apositivemateriality 7/10

20-03-2026

Claritev Corporation's 2026 proxy statement invites stockholders to the virtual Annual Meeting on April 29, 2026, for electing four Class III directors (Anthony Colaluca, Jr., Michael S. Klein, Allen R. Thorpe, Dale A. White), ratifying PwC as auditors for FY2026, approving NEO compensation on an advisory basis, and amending the 2020 Omnibus Incentive Plan. CEO Travis Dalton highlighted 2025 achievements including positive revenue growth, improved Adjusted EBITDA and free cash flow, expansion into new markets, and over $67M in new Annual Contract Value, with no declines noted. The company is advancing Vision 2030 through 'The Way Up' phase focused on disciplined growth and AI integration.

  • ·Annual Meeting: April 29, 2026 at 9:00 a.m. EDT, virtual at www.virtualshareholdermeeting.com/CTEV2026
  • ·Record date: March 6, 2026
  • ·Proposals: 1) Elect 4 Class III directors; 2) Ratify PwC for FY2026; 3) Advisory vote on NEO pay; 4) Approve amendment to 2020 Omnibus Incentive Plan
OLIN CorpDEF 14Aneutralmateriality 4/10

20-03-2026

Olin Corporation filed its DEF 14A definitive proxy statement on March 20, 2026, for the annual shareholder meeting with a conformed period end of April 30, 2026, detailing voting procedures, deadlines, and access to the 2025 Form 10-K. The Olin Retirement Savings Plan held 1,267,968 shares of common stock as of March 2, 2026, with voting instructions due by April 27, 2026, for RSP participants and April 29, 2026, for others. The filing includes references to executive compensation disclosures for Kenneth T. Lane and Scott M. Sutton covering 2021-2025 but provides no specific financial metrics or performance changes.

  • ·Annual meeting voting deadline for non-RSP shareholders: April 29, 2026 by 11:59 p.m. Eastern Time
  • ·RSP voting instructions deadline: April 27, 2026 by 11:59 p.m. Eastern Time
  • ·Shareholder proposals for 2027 annual meeting (exclusion notice): no earlier than December 2, 2026 and no later than January 1, 2027
  • ·Shareholder proposals for inclusion in 2027 proxy: no later than November 21, 2026
  • ·Director nomination recommendations for 2027: no later than October 22, 2026
  • ·No person beneficially owned more than 5% of common stock as of March 2, 2026, except as listed (table incomplete in filing excerpt)
Latham Group, Inc.DEF 14Apositivemateriality 8/10

20-03-2026

In 2025, Latham Group grew net sales 7.4% YoY to $545.9M and expanded gross margins by 320 basis points, achieving net income of $11.1M and Adjusted EBITDA of $99.8M, while outperforming a U.S. in-ground pool market that declined low- to mid-single digits; fiberglass pools reached 76.5% of total in-ground pool sales with double-digit growth in Florida. Acquisitions of Coverstar Central (Aug 2024) and Coverstar New York/Tennessee (early 2025) contributed to margin gains. The proxy statement solicits votes for the April 30, 2026 Annual Meeting on electing three Class II directors, ratifying Deloitte & Touche LLP as auditors for 2026, and approving an amendment to add 3,400,000 shares to the 2021 Omnibus Equity Incentive Plan.

  • ·U.S. in-ground pool starts declined low- to mid-single digits in 2025
  • ·Annual Meeting on April 30, 2026 at 8:00 a.m. EDT at The Adelphi Hotel, 365 Broadway, Saratoga Springs, NY 12866
  • ·Record date for stockholders: March 3, 2026
  • ·Approximately 65 years operating history
  • ·Average dealer relationship tenure over 15 years
E.W. SCRIPPS CoDEF 14Aneutralmateriality 7/10

20-03-2026

The E.W. Scripps Company (SSP) filed its DEF 14A Proxy Statement on March 20, 2026, for the 2026 Annual Meeting of Shareholders on May 4, 2026, at 4:00 PM ET in Cincinnati, OH, with record date March 10, 2026. Key proposals include election of directors, ratification of Deloitte & Touche LLP as independent auditors for 2026, advisory vote on 2025 named executive officer compensation, and ratification of the Shareholder Rights Plan adopted November 25, 2025, with the Board recommending FOR all items. The filing includes 2025 executive compensation disclosures (e.g., Summary Compensation Table, equity awards, pension benefits) and director compensation details for 2021-2025 periods.

  • ·Annual Meeting location: Scripps Center, 312 Walnut Street, 10th Floor Conference Center, Cincinnati, Ohio
  • ·Proxy materials furnished via Notice of Internet Availability on or about March 20, 2026
  • ·Compensation disclosures cover PEO and Non-PEO NEO for periods 2021-2025, including equity awards adjustments, pension service costs, and change in fair value of outstanding equity
HACKETT GROUP, INC.DEF 14Aneutralmateriality 6/10

20-03-2026

The Hackett Group, Inc. (HCKT) filed its DEF 14A proxy statement for the 2026 Annual Meeting on April 30, 2026, seeking shareholder approval for electing one director nominee, amending the Employee Stock Purchase Plan to add 250,000 authorized shares and extend its term to July 1, 2031, an advisory vote on executive compensation, and ratification of RSM US LLP as auditors for the fiscal year ending January 1, 2027. The record date is March 13, 2026, with proxy materials distributed on or about March 20, 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing.

  • ·Annual Meeting location: 1001 Brickell Bay Drive, 30th Floor, Miami, Florida at 11:00 a.m. local time
  • ·Fiscal year for auditor ratification ends January 1, 2027
  • ·Shareholder list available for examination 10 days prior to meeting
Orion Properties Inc.DEF 14Aneutralmateriality 5/10

20-03-2026

Orion Properties Inc. (ONL) issued its 2026 DEF 14A Proxy Statement for the virtual Annual Meeting on May 13, 2026 (record date March 13, 2026), seeking stockholder approval to elect five director nominees and ratify KPMG LLP as independent auditor for FY ending December 31, 2026. As of December 31, 2025, the portfolio includes 58 operating properties (6.5M sq ft across 26 states) and a 20% interest in a JV with six properties (1.0M sq ft), totaling 6.7M rentable sq ft at 78.7% occupancy (78.2% adjusted for properties under sale agreements). The company, a REIT spun off from Realty Income in 2021, remains an emerging growth company until December 31, 2026.

  • ·Annual Meeting at 11:30 A.M. ET, virtual via www.virtualshareholdermeeting.com/ONL2026.
  • ·Weighted average remaining lease term of 5.7 years as of Dec 31, 2025.
  • ·Common stock par value $0.001 per share.
  • ·Company will lose emerging growth company status on Dec 31, 2026.
  • ·Principal office: 3200 E Camelback Road, Suite 100, Phoenix, Arizona 85018.
GILEAD SCIENCES, INC.DEF 14Apositivemateriality 8/10

20-03-2026

Gilead Sciences' 2026 Definitive Proxy Statement (DEF 14A) provides executive compensation disclosures for PEO Daniel O’Day and other NEOs across 2021-2025, alongside letters highlighting 2025 achievements including record HIV sales from Biktarvy, successful Yeztugo launch for HIV prevention, positive Trodelvy data in breast cancer, and an agreement to acquire Arcellx for anito-cel advancement. The Board emphasizes oversight of HIV leadership extension into the 2040s, oncology and inflammation pipeline progress with Livdelzi adoption and potential bulevirtide launch in 2026, AI Principles rollout in February 2025, and no major loss of exclusivity for the decade ahead. No declines or flat performance noted in the provided content.

  • ·Arcellx acquisition agreement subject to customary closing conditions.
  • ·Potential U.S. launch of bulevirtide for chronic hepatitis delta in 2026.
  • ·Up to seven potential HIV treatment and prevention launches by 2033.
PREFORMED LINE PRODUCTS CODEF 14Aneutralmateriality 5/10

20-03-2026

Preformed Line Products Company's DEF 14A proxy statement, filed March 20, 2026, solicits votes for the annual shareholder meeting on May 4, 2026, including election of four directors for terms expiring 2028, an advisory vote on Named Executive Officer compensation, and ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026. As of the March 5, 2026 record date, 4,896,855 common shares were outstanding, with concentrated ownership including Robert G. Ruhlman at 30.1% (1,475,081 shares) and Randall M. Ruhlman at 23.4% (1,147,610 shares); all executives and directors held 33.0% (1,615,502 shares). No financial performance metrics or compensation amounts are detailed in the provided filing content.

  • ·Record date for voting eligibility: March 5, 2026
  • ·Annual meeting location: 660 Beta Drive, Mayfield Village, Ohio 44143, at 9:30 a.m. local time
  • ·Quorum requires majority of voting power present in person or by proxy
  • ·Broker non-votes applicable to director election and NEO compensation vote but not auditor ratification
HUNTINGTON INGALLS INDUSTRIES, INC.DEF 14Apositivemateriality 6/10

20-03-2026

Huntington Ingalls Industries, Inc. (HII) filed its DEF 14A Proxy Statement on March 20, 2026, ahead of the 2026 Annual Meeting, disclosing detailed executive compensation data under pay versus performance rules for Principal Executive Officer Christopher D. Kastner (2022-2025) and former PEO C. Michael Petters (2021-2022), including equity awards, pension adjustments, and fair value changes. 2025 performance highlights note increased hiring and retention in partnership with government customers, along with improved proficiency levels. Proxy materials, including the 2025 Annual Report, will be available online on or about March 20, 2026.

  • ·Proxy materials for 2026 Annual Meeting to be mailed via Notice of Internet Availability to stockholders of record.
  • ·Compensation disclosures cover Summary Compensation Table adjustments, equity awards granted and vested, pension service costs for PEO and Non-PEO NEOs from 2021-2025.
AMERIPRISE FINANCIAL INCDEF 14Apositivemateriality 9/10

20-03-2026

Ameriprise Financial delivered strong 2025 adjusted financial performance, including net revenues of $18.2B (up 6% YoY), adjusted earnings of $3.9B (up 7% YoY), adjusted EPS of $39.34 (up 12% YoY), and AUMAA of $1.7T (up 11% YoY). The company returned $3.4B to shareholders (up 20% YoY) amid a 26.9% adjusted margin (up 40 bps) and 53.3% ROE excluding AOCI (up 60 bps). At the April 29, 2026 virtual annual meeting, shareholders will vote on electing eight director nominees, ratifying PricewaterhouseCoopers LLP as auditors, and approving NEO compensation on an advisory basis.

  • ·Annual shareholder meeting: April 29, 2026 at 11:00 a.m. Central time (virtual at www.virtualshareholdermeeting.com/amp2026)
  • ·Record date: March 2, 2026
  • ·21st consecutive quarterly dividend increase since 2005
  • ·7 of 8 director nominees are independent
  • ·Directors cannot be nominated after age 75
Ascend Wellness Holdings, Inc.DEF 14Aneutralmateriality 3/10

20-03-2026

Ascend Wellness Holdings, Inc. (AAWH) filed a DEF 14A proxy statement dated March 20, 2026, soliciting proxies for its annual general meeting. Shareholders can submit proxies online prior to 11:00 a.m. ET on April 27, 2026, or attend the virtual AGM using meeting ID 400-906-287-553 and password 'ascend2026'. No financial results, performance metrics, or material proposals are detailed in the provided content.

  • ·Virtual AGM access: https://web.lumiagm.com (Meeting ID: 400-906-287-553; Password: ascend2026)
  • ·Online voting: https://vote.odysseytrust.com (requires control number)
  • ·Proxy voting deadline: 11:00 a.m. ET, Monday, April 27, 2026
Lantheus Holdings, Inc.DEF 14Aneutralmateriality 6/10

20-03-2026

Lantheus Holdings, Inc.'s DEF 14A proxy statement, filed March 20, 2026, discloses 2025 equity grants to non-employee directors of 2,537 RSUs and stock options for 4,543 shares each on May 14, 2025, with unvested holdings detailed as of December 31, 2025. Beneficial ownership as of the March 6, 2026 record date shows Mary Anne Heino holding 664,744 shares (1.0%), Brian A. Markison holding 180,678 shares, and other directors and NEOs holding smaller stakes, with 64,971,604 shares outstanding. All directors meet or are within the five-year compliance period for stock ownership guidelines requiring three times the annual cash retainer.

  • ·Record date for beneficial ownership: March 6, 2026
  • ·2025 Form 10-K filed with SEC on February 26, 2026
  • ·Dr. Morrow received initial grant of 563 RSUs and 1,015 stock options on February 7, 2025, plus annual grant
  • ·All non-employee directors subject to short-term trading, hedging, and pledging prohibitions
Broadstone Net Lease, Inc.DEF 14Aneutralmateriality 6/10

20-03-2026

Broadstone Net Lease, Inc. (BNL) filed its DEF 14A proxy statement on March 20, 2026, for the virtual Annual Meeting of Stockholders on April 30, 2026, at 1:00 p.m. ET, with a record date of March 2, 2026, entitling holders of 191.6M shares of common stock to vote. Proposals include electing directors for the ensuing year, a non-binding advisory vote on named executive officer compensation, and ratifying Deloitte & Touche LLP as independent auditors for the year ending December 31, 2026; no performance metrics or changes are detailed in the filing.

  • ·Annual Meeting attendance requires advance registration by April 27, 2026 at 5:00 p.m. ET at www.proxydocs.com/BNL
  • ·Proxy materials and Annual Report for fiscal year ended December 31, 2025 available at www.proxydocs.com/BNL
  • ·Common Stock par value: $0.00025 per share
HORIZON BANCORP INC /IN/DEF 14Aneutralmateriality 5/10

20-03-2026

Horizon Bancorp, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Shareholders, to be held virtually on May 7, 2026, at 10:00 a.m. CDT, with a record date of March 13, 2026. Shareholders will vote on electing four directors for three-year terms expiring in 2029, an advisory (non-binding) vote to approve executive compensation, and ratification of Forvis Mazars, LLP as the independent registered public accounting firm for 2026. The proxy materials and Annual Report for the year ended December 31, 2025, are available online, with printed copies available upon request.

  • ·Virtual meeting access: www.meetnow.global/MGRACXW using 15-digit control number.
  • ·Street name holders must register legal proxy by April 17, 2026, 9:00 a.m. CDT.
  • ·Proxy materials mailed as Notice on March 18, 2026; available at www.investorvote.com/hbnc.
ELI LILLY & CoDEF 14Apositivemateriality 9/10

20-03-2026

Eli Lilly's 2026 Proxy Statement outlines the May 4, 2026 virtual annual shareholder meeting, recommending votes FOR electing four director nominees, advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as 2026 auditor, and amendments to declassify the board and eliminate supermajority voting provisions. 2025 performance highlights include $65.2B revenue, $22.95 reported EPS ($24.21 non-GAAP), 40% TSR exceeding S&P 500 and pharma peers, FDA approvals for Kisunla and Omvoh updates, superior Zepbound trial results (20.2% average weight loss vs. 13.7% for Wegovy), orforglipron Phase 3 data, Verve Therapeutics acquisition, and over $15.7B in manufacturing investments. The board recommends AGAINST shareholder proposals for an independent board chair and annual lobbying report.

  • ·Annual meeting: May 4, 2026, 9:30 a.m. EDT, virtually at www.virtualshareholdermeeting.com/LLY2026
  • ·Record date: February 25, 2026
  • ·401(k) Plan shareholders must vote by April 29, 2026
  • ·Peer group for TSR: pharma executive compensation peers plus Novo Nordisk
WILSON BANK HOLDING CODEF 14Apositivemateriality 7/10

20-03-2026

Wilson Bank Holding Company (WBHC) highlights strong 2025 performance in its DEF 14A proxy statement, with total assets exceeding $5B and loan growth of $259.2M driven by relationship banking and stable core deposits. The filing accompanies notice for the April 23, 2026 annual shareholder meeting to elect four Class I directors for three-year terms and ratify RubinBrown LLP as independent auditors for FY 2026. No declines or flat metrics are disclosed.

  • ·Annual meeting on Thursday, April 23, 2026 at 5:00 p.m. CDT at Clemons-Richerson Operations Center, 105 North Castle Heights Avenue, Lebanon, TN 37087
  • ·Elect four Class I directors to hold office for three years until successors elected and qualified
  • ·Ratify appointment of RubinBrown LLP as independent registered public accounting firm for fiscal year ending December 31, 2026
  • ·2025 Annual Report enclosed highlighting financial performance
BRINKS CODEF 14Apositivemateriality 7/10

20-03-2026

Brink’s 2026 Proxy Statement (DEF 14A filed March 20, 2026) emphasizes robust corporate governance, including 89% independent directors (8 of 9 nominees), separate CEO and independent Chairman roles, annual director elections, and majority vote standard. The Board provides oversight on strategy, risk management, CEO succession, ERM, sustainability, and newly delegated IT/cybersecurity to the Audit Committee. Nine director nominees feature diverse expertise with an average tenure of 8.8 years; no declines or flat metrics noted in governance practices.

  • ·All standing Board committees composed entirely of independent directors
  • ·Shareholder proxy access rights for eligible shareholders
  • ·Mandatory director retirement age policy with no waivers
  • ·2025 launch of global continuing director education program
PENSKE AUTOMOTIVE GROUP, INC.DEF 14Apositivemateriality 8/10

20-03-2026

Penske Automotive Group, Inc. (PAG) filed its 2026 definitive Proxy Statement for the virtual annual stockholder meeting on May 13, 2026, seeking approval to elect 12 directors, ratify Deloitte & Touche LLP as independent auditor, and provide an advisory vote on named executive officer compensation. For fiscal 2025, PAG reported strong results including $31.8B in revenue, $938M net income, $14.13 EPS, delivery of over 485,000 vehicles and 19,000 commercial trucks, acquisitions adding $1.6B in expected annualized revenue, quarterly dividend increases, and $182M in share repurchases representing 1.8% of shares outstanding. The company noted industry challenges but emphasized its strong balance sheet, cash flow, and ~27,400 team members driving operational excellence.

  • ·Annual meeting: May 13, 2026 at 8:00 a.m. EDT, virtual at www.virtualshareholdermeeting.com/PAG2026
  • ·Record date: March 20, 2026
  • ·Stockholders agreement between affiliates of Roger Penske and Mitsui & Co., Ltd. for voting on Board members
PENTAIR plcDEF 14Amixedmateriality 8/10

20-03-2026

Pentair plc's 2026 proxy statement highlights record 2025 performance with adjusted operating income up 10% YoY to $1,053.5M, adjusted EPS up 14% to $4.92, and free cash flow up 8% to $748.4M, alongside a quarterly dividend increase from $0.23 to $0.25 per share. However, sales growth was modest at only 2% YoY to $4.2B, reflecting flat top-line performance. The AGM on May 5, 2026, seeks re-election of nine directors (with David A. Jones retiring), advisory approval of NEO compensation, auditor ratification, and share allotment authorizations.

  • ·Adjusted return on sales of 25.2% in FY2025, up 170bps YoY.
  • ·ROIC of 16.7% in FY2025.
  • ·Organizational changes: Combined Flow Residential business with Residential business within Water Solutions.
  • ·Record date for voting: March 6, 2026.
  • ·Proxy submission deadlines: April 30, 2026 (11:59 p.m. EDT) for certain plans; May 4, 2026 (11:59 p.m. EDT) for others.
Shoals Technologies Group, Inc.DEF 14Aneutralmateriality 6/10

20-03-2026

Shoals Technologies Group, Inc. (SHLS) filed its DEF 14A Proxy Statement on March 20, 2026, for the virtual Annual Meeting of Shareholders on April 30, 2026, at 10:00 a.m. Eastern Time, with a record date of March 10, 2026. Key proposals include electing five director nominees (Ty Daul, Jeannette Mills, Niharika Taskar Ramdev, Lori Sundberg, and Toni Volpe), an advisory vote to approve executive compensation, and ratification of Ernst & Young LLP as independent auditors for fiscal year 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing summary.

  • ·Virtual meeting access: www.virtualshareholdermeeting.com/SHLS2026; proxy materials at www.proxyvote.com/SHLS2026
  • ·Fiscal year end: December 31; references 2025 Form 10-K for performance details
  • ·Director ages: Ty Daul (58), Jeannette Mills (59), Niharika Taskar Ramdev (56), Lori Sundberg (62), Toni Volpe (53)
Katapult Holdings, Inc.DEF 14Aneutralmateriality 6/10

20-03-2026

Katapult Holdings, Inc. filed its DEF 14A proxy statement dated March 20, 2026, for the virtual 2026 Annual Meeting of Stockholders on April 30, 2026, at 10:00 a.m. ET. Shareholders are asked to vote on electing Derek Medlin as the Class II director nominee to serve until the 2029 Annual Meeting, ratifying Grant Thornton LLP as independent auditor for the fiscal year ending December 31, 2026, and approving executive compensation on a non-binding advisory basis, with a record date of March 16, 2026. The Board highlights strong corporate governance, including 3 out of 5 independent directors and policies prohibiting hedging and pledging.

  • ·Annual Meeting held virtually only at www.virtualshareholdermeeting.com/KPLT2026; no physical location.
  • ·Director election by plurality vote.
  • ·Nominee Derek Medlin is not independent, age 43.
  • ·Corporate governance includes independent committees, no single-trigger change in control provisions, and equity ownership guidelines.
Emergent BioSolutions Inc.DEF 14Amateriality 6/10

20-03-2026

ECOLAB INC.DEF 14Apositivemateriality 7/10

20-03-2026

Ecolab's 2026 DEF 14A Proxy Statement details robust corporate governance practices, including adoption of a global AI policy, annual board and committee evaluations, and perfect director attendance with all serving at least 80% of the 5 Board meetings held in 2025. Non-employee directors received base annual compensation of $315,000 plus retainers, with total 2025 compensation ranging from $92,143 to $377,777, and all comply with stock ownership guidelines of 5x the annual retainer; no related person transactions exceeded $120,000 since 2025.

  • ·Stockholder director recommendations for 2027 Annual Meeting due to Corporate Secretary by January 7, 2027.
  • ·Director equity vesting updated for grants on/after December 4, 2025 to earlier of 12 months or next annual meeting.
  • ·No related person transactions since beginning of 2025 or currently anticipated.
  • ·Governance Committee oversees political contributions and trade association memberships annually.
AVALON HOLDINGS CORPDEF 14Amixedmateriality 7/10

20-03-2026

Avalon Holdings Corp's DEF 14A proxy statement discloses 2025 executive compensation, with CEO Ronald E. Klingle's total pay declining 5% YoY to $255,000 amid flat salary and lower bonus, while AWMS CEO Kenneth J. McMahon's total fell 10% to $480,669 on reduced performance-based bonus; CFO Michael J. Havalo's pay rose slightly 1% to $207,303. This aligns with weaker performance including net income dropping 76% YoY to $321,000 from $1.318M and shareholder return falling to $67 from $159. The filing seeks an advisory 'say-on-pay' vote and notes no equity awards, expired options, and no 401(k) contribution for 2025.

  • ·Company is a controlled company with over 50% voting power held by Mr. Klingle; Compensation Committee not fully independent.
  • ·No discretionary contribution to 401(k) Profit Sharing Plan for 2025.
  • ·All prior stock options under Long-Term Incentive Plan expired; no outstanding equity awards at Dec 31, 2025.
  • ·Non-employee directors received $24,000 in fees with no equity grants.
  • ·AWMS Holdings LLC offers private placement to accredited investors for salt water facilities; consolidated due to control despite not majority owner.
Heritage Distilling Holding Company, Inc.DEF 14Aneutralmateriality 8/10

20-03-2026

IP Strategy Holdings, Inc. (IPST) filed a definitive proxy statement for a virtual special stockholder meeting on April 10, 2026, seeking approval for a reverse stock split of its common stock at a ratio between 1:3 and 1:20, without reducing authorized shares, with the board to select the timing and exact ratio by June 30, 2026. A secondary adjournment proposal allows delaying the meeting if needed to solicit more votes. The board unanimously recommends voting 'FOR' both proposals, requiring a majority of votes cast; 10,283,427 common shares were outstanding as of the March 19, 2026 record date.

  • ·Common stock par value: $0.0001 per share
  • ·Virtual meeting webcast: www.virtualshareholdermeeting.com/IPSTSM2026
  • ·Voting deadline: 11:59 p.m. ET on April 9, 2026
  • ·Approval threshold: majority of votes cast by stockholders present virtually or by proxy
GLADSTONE COMMERCIAL CORPDEF 14Aneutralmateriality 4/10

20-03-2026

This DEF 14A proxy statement for Gladstone Commercial Corp covers the fiscal year ended December 31, 2025, detailing the composition, independence, and charters of its Audit, Compensation, Ethics/Nominating/Governance, Executive, and Offering Committees. All members and alternates, including Messrs. Parker, Outland, Wilkinson, Gladstone and Mses. English and Gorka, are confirmed independent under Nasdaq standards, with several also serving on committees of affiliated Gladstone entities without impairment to their service. The statement outlines director nomination processes, minimum qualifications (e.g., over 21 years old, financial literacy), and stockholder submission requirements, including no controversies noted in committee interlocks or ethics violations.

  • ·Stockholder director nominations must be received no earlier than February 6, 2027, and no later than March 8, 2027, for the 2027 Annual Meeting expected around May 7, 2027.
  • ·Corporate address: 1521 Westbranch Drive, Suite 100, McLean, Virginia 22102.
  • ·Committee charters available at www.GladstoneCommercial.com in Governance section.
  • ·No fees paid to third parties for director candidate identification to date.
  • ·No stockholder director nominee proposals received or rejected to date.
PARKE BANCORP, INC.DEF 14Aneutralmateriality 7/10

20-03-2026

Parke Bancorp, Inc., the holding company for Parke Bank, has issued a proxy statement for its virtual Annual Meeting on April 21, 2026, seeking shareholder approval for the election of three directors (including nominees Vito S. Pantilione and Edward Infantolino), ratification of S.R. Snodgrass, P.C. as independent auditors for the fiscal year ending December 31, 2026, and non-binding advisory votes on executive compensation and its frequency (recommending every three years). As of the March 11, 2026 Record Date, 11,730,950 shares of common stock were outstanding, with principal holders BlackRock, Inc. (686,968 shares, 5.86%) and Fourthstone LLC (620,899 shares, 5.29%), and directors/executive officers as a group owning 1,493,718 shares (12.47%). No financial performance metrics or period-over-period changes are disclosed in the filing.

  • ·Annual Meeting quorum requires majority of outstanding shares (virtual webcast at www.meetnow.global/MZS4KXT).
  • ·Registration deadline for beneficial owners: April 14, 2026, 5:00 p.m. ET.
  • ·Directors elected by plurality vote; other proposals by majority of votes cast.
  • ·Board recommends 'FOR' all proposals, including say-on-pay every three years.
PERRIGO Co plcDEF 14Aneutralmateriality 7/10

20-03-2026

Perrigo Company plc's DEF 14A Proxy Statement, filed March 20, 2026, outlines the 2026 Annual General Meeting on April 30, 2026 (record date March 2, 2026), seeking shareholder approval for electing nine directors, ratifying Ernst & Young LLP as independent auditor (with Board authorization to set fees), advisory approval of executive compensation, approval of the 2026 Long-Term Incentive Plan, and renewal of Board authorities to issue shares and opt-out of pre-emption rights under Irish law. The filing includes XBRL-tagged compensation data for Principal Executive Officer (PEO) P. Lockwood Taylor for 2023-2025 and former PEO M. Kessler for 2021-2023, covering equity awards, fair value changes, and vesting details. No specific financial performance metrics or period-over-period changes are detailed in the provided content.

  • ·AGM location: 25 North Wall Quay, Dublin 1, D01 H104, Ireland
  • ·Proposals 1-5: ordinary resolutions (simple majority); Proposal 6: special resolution (75% approval required)
  • ·Consideration of Irish Statutory Financial Statements for fiscal year ended December 31, 2025
  • ·Proxy materials available at www.materials.proxyvote.com/G97822
GOLDMAN SACHS GROUP INCDEF 14Amixedmateriality 8/10

20-03-2026

Goldman Sachs reported strong 2025 performance with net revenues of $58.3B (+9% YoY, ex-Apple Card transition $60.5B), pre-tax earnings of $21.9B (+19% YoY), EPS of $51.32 (+27% YoY), ROE of 15.0% (+230 bps YoY), and ROTE of 16.0% (+250 bps YoY), alongside shareholder value creation including +54% stock price growth and +57% TSR. However, the efficiency ratio worsened to 64.4% (+1.3 percentage points YoY), and BVPS growth was modest at +6.2%. The proxy statement outlines the April 29, 2026 annual meeting agenda, including director elections, say-on-pay, auditor ratification, and shareholder proposals (board recommends against the latter), with board changes like Lakshmi Mittal's retirement and recent additions of KC McClure and John Waldron.

  • ·Board held 71 meetings and extensive engagements in 2025.
  • ·Shareholder engagements covered >35% of shares outstanding.
  • ·Acquisitions of Industry Ventures and Innovator Capital Management; strategic partnership and investment in T. Rowe Price.
  • ·Completed transition of GM credit card; announced Apple Card transition to narrow consumer focus.
  • ·Annual Meeting: April 29, 2026, 8:30 a.m., Salt Lake City; Record Date March 2, 2026.
Inspire Medical Systems, Inc.DEF 14Apositivemateriality 8/10

20-03-2026

Inspire Medical Systems, Inc. reported strong FY2025 performance with $912M in revenue, up 14% YoY from FY2024, surpassing 125,000 patients treated with Inspire therapy, and launching the Inspire V neurostimulation system while achieving strong gross and operating margins. Leadership was enhanced with Matt Osberg as CFO in early 2026 and Carlton Weatherby elevated to Chief Strategy and Growth Officer following Randy Ban's retirement. The proxy statement outlines proposals for electing three Class II directors, ratifying Ernst & Young as auditors, advisory votes on executive compensation and frequency, declassifying the board starting 2029, amending the 2018 Incentive Award Plan, and potential adjournment.

  • ·Annual meeting on April 30, 2026 at 9:00 a.m. ET via virtual webcast at www.virtualshareholdermeeting.com/INSP2026
  • ·Record date: March 2, 2026
  • ·Proposal 5 requires two-thirds majority approval
  • ·Over 80% of employees participated in broad-based equity compensation in 2025
Terreno Realty CorpDEF 14Aneutralmateriality 7/10

20-03-2026

Terreno Realty Corp's DEF 14A proxy statement, filed March 20, 2026, for the annual stockholder meeting on May 5, 2026, outlines corporate governance practices, including a board structure with 75% independent directors post-election (Gary N. Boston, LeRoy E. Carlson, Paul J. Donahue, Jr., Constance von Muehlen, Irene H. Oh, and Douglas M. Pasquale), combined Chairman and CEO roles held by Mr. Baird, and Lead Director Mr. Pasquale providing independent oversight. It details director nomination processes, risk oversight by the board and audit committee, executive sessions, and confirms no compensation committee interlocks or insider participation issues during 2025. The statement also references FY2025 executive compensation disclosures via XBRL tags for PEO and Non-PEO NEOs covering equity awards and fair value changes.

  • ·Annual meeting date: May 5, 2026
  • ·Stockholder nomination notice deadline: 120th to 150th day prior to first anniversary of prior year's meeting notice
  • ·Investor Relations contact: (415) 655-4580 or 10500 NE 8th Street, Suite 1910, Bellevue, WA 98004
  • ·Compensation committee members for FY2025: Boston, Pasquale, Carlson, von Muehlen, Oh (full year); Polk and Donahue (part year)
  • ·Governance documents available at https://investors.terreno.com/corporate-profile/documents
CORNING INC /NYDEF 14Apositivemateriality 8/10

20-03-2026

Corning Incorporated's 2026 DEF 14A proxy statement outlines proposals for the April 30, 2026 virtual annual meeting, including election of 10 directors, advisory approval of 2025 executive compensation, ratification of the independent auditor, and opposition to a shareholder proposal for an independent chair policy. The company reported strong 2025 performance with GAAP net sales of $15.629B and diluted EPS of $1.83, while core net sales reached $16.408B and core diluted EPS was $2.52, supported by cash flows from operating activities of $2.695B and adjusted free cash flow of $1.717B. No declines or flat metrics were highlighted in the performance overview.

  • ·Annual shareholder meeting: April 30, 2026, 12 noon Eastern Time, virtual at virtualshareholdermeeting.com/GLW2026
  • ·Record date: March 2, 2026
  • ·Fiscal year end: December 31
  • ·Proxy materials posted/mailing began: March 20, 2026
Duke Energy CORPDEF 14Aneutralmateriality 6/10

20-03-2026

Duke Energy's 2026 Proxy Statement details 2025 director compensation including annual stock retainers of 1,607 shares each (plus 824 additional shares for Independent Chair Craver and prorated 1,005 for new director Guldner), with all other compensation ranging from $4,360 to $9,536 per director. Security ownership as of March 1, 2026 shows insiders and directors holding less than 1% of 778.1M outstanding shares, while major shareholders Vanguard (10%), BlackRock (7.52%), and State Street (5.42%) own significant portions as of December 31, 2025. Deloitte & Touche LLP fees rose 28% YoY to $19.8M in 2025 from $15.4M in 2024, driven by higher audit fees (+26%) and audit-related fees (+75%), with Proposal 2 seeking shareholder ratification for 2026.

  • ·Prohibition on hedging, pledging, and short-selling Duke Energy securities for directors, officers, employees, and related persons.
  • ·Deloitte has served as independent auditor since 1947; lead engagement partner rotates every 5 years, last approved in 2024.
  • ·No Tax Fees billed by Deloitte in 2025 or 2024.
CPS TECHNOLOGIES CORP/DE/DEF 14Aneutralmateriality 6/10

20-03-2026

CPS Technologies Corp. (CPSH) has issued a proxy statement for its 2026 Annual Meeting on April 30, 2026, seeking stockholder approval for electing five directors, advisory votes on executive compensation and its frequency, amending the Certificate of Incorporation to increase authorized common shares from 20,000,000 to 25,000,000 ($0.01 par value), and ratifying PKF O’Connor Davies LLP as auditor for the fiscal year ending December 26, 2026. The record date is March 11, 2026, with 18,006,963 shares of common stock outstanding and entitled to vote. No financial performance metrics or period-over-period comparisons are provided in the filing.

  • ·Meeting location: offices of Nutter McClennen & Fish LLP, 155 Seaport Blvd., Boston, Massachusetts 02210, at 10:00 a.m. local time.
  • ·Proxy materials available at https://cpstechnologysolutions.com/financial-reports/ under 'All SEC Filings' on or about March 20, 2026.
  • ·All proposals except auditor ratification and share increase amendment are non-routine, potentially leading to broker non-votes.
Holley Inc.DEF 14Aneutralmateriality 7/10

20-03-2026

Holley Inc. (HLLY-WT) filed its 2026 Definitive Proxy Statement (DEF 14A) on March 20, 2026, for the virtual annual meeting of stockholders on May 1, 2026, at 8:00 a.m. Central Time. The meeting agenda includes election of directors, ratification of Grant Thornton LLP as independent auditor for fiscal 2026, advisory vote on executive compensation (Say-on-Pay), frequency of future Say-on-Pay votes (recommended annually), and approval of an amendment to the 2021 Omnibus Incentive Plan to increase authorized common stock shares. The Board unanimously recommends voting FOR all proposals as outlined.

  • ·Record Date: March 9, 2026
  • ·Business Combination Closing Date: July 16, 2021
  • ·Virtual Meeting URL: www.virtualshareholdermeeting.com/HLLY2026
  • ·Proxy Materials Availability: www.proxyvote.com
  • ·Investor Website: https://investor.holley.com
DOUGLAS DYNAMICS, INCDEF 14Aneutralmateriality 6/10

20-03-2026

Douglas Dynamics, Inc. (PLOW) filed a DEF 14A proxy statement on March 20, 2026, disclosing beneficial ownership of more than 5% of its common stock by major institutional investors including Allspring Global Investments Holdings, LLC (10.27%), Conestoga Capital Advisors LLC (10.14% as of December 31, 2023), Pzena Investment Management LLC (10.07%), BlackRock, Inc. (7.09%), and The Vanguard Group (5.86%). The filing includes pay versus performance compensation disclosures for principal executive officers (PEOs) Mr. McCormick (2021-2024), Mr. Janik (2025), and other named executive officers (NEOs), as well as confirmations of no compensation committee interlocks or material related party transactions exceeding $120,000 since December 31, 2024.

  • ·No members of the Compensation Committee are officers or employees of the Company.
  • ·None of the Company's executive officers serve on the board or compensation committee of entities with executives on PLOW's Board or Compensation Committee.
  • ·No related party transactions since December 31, 2024 exceeding $120,000 involving directors, executive officers, or >5% beneficial owners.
FIDUS INVESTMENT CorpDEF 14Aneutralmateriality 7/10

20-03-2026

Fidus Investment Corp's DEF 14A proxy statement details the Annual Meeting on June 10, 2026, at 8:30 a.m. CT in Evanston, IL, for electing two Class III directors (Proposal 1) and approving authority to issue common stock below NAV per share during the next year, limited to 25% of outstanding shares (Proposal 2). Record date is March 19, 2026, with 37,954,364 shares outstanding requiring a quorum of over 18,977,182 shares; Board recommends voting FOR both proposals. No financial performance metrics or period comparisons are provided.

  • ·Voting deadlines: Internet/telephone until 11:59 p.m. ET on June 9, 2026.
  • ·Stockholder proposals for 2027 Annual Meeting due no earlier than September 21, 2026, and no later than 5:00 p.m. ET November 20, 2026.
  • ·Annual Report and proxy materials available at https://web.viewproxy.com/fidusinv/2026/; sent to stockholders on or about March 26, 2026.
  • ·Proposal 2 requires majority of outstanding shares and majority excluding affiliates (1940 Act Majority); abstentions count as votes against.
BOYD GAMING CORPDEF 14Aneutralmateriality 6/10

20-03-2026

Boyd Gaming Corporation's DEF 14A proxy statement for the 2026 Annual Meeting seeks stockholder approval for the election of eight directors, ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, and an advisory vote on executive compensation. The virtual meeting is scheduled for May 7, 2026, at 1:00 p.m. PT, with a record date of March 10, 2026. The filing includes compensation disclosures via XBRL tags for PEO and Non-PEO NEOs across 2021-2025 but provides no specific numerical values.

  • ·Virtual Annual Meeting at http://www.virtualshareholdermeeting.com/BYD2026.
  • ·Record date: close of business on March 10, 2026.
  • ·Compensation disclosures cover periods 2021-2025 for PEO and Non-PEO NEOs including equity awards, changes in fair value, and dividends.
  • ·Filed on March 20, 2026.
LOUISIANA-PACIFIC CORPDEF 14Aneutralmateriality 6/10

20-03-2026

Louisiana-Pacific Corporation (LPX) 2026 Proxy Statement solicits votes for the May 1, 2026 virtual Annual Meeting to elect three Class II directors (Jose A. Bayardo, Stephen E. MacAdam, Jean-Michel Ribieras), ratify Deloitte & Touche LLP as independent auditors for 2026, and approve named executive officer compensation on an advisory basis; the Board recommends FOR all proposals. The Board consists of 10 members with 9 independent directors, featuring strong governance practices including majority voting and stock ownership guidelines. Two long-serving directors, Ozey K. Horton, Jr. and Dustan E. McCoy, are retiring at the meeting.

  • ·Record date: March 3, 2026 (stockholders of record entitled to vote).
  • ·Meeting: Friday, May 1, 2026 at 7:30 a.m. Central Time via live audio webcast at http://www.virtualshareholdermeeting.com/LPX2026.
  • ·Proxy materials available on or about March 20, 2026.
  • ·References Form 10-K for year ended December 31, 2025.
X4 Pharmaceuticals, IncDEF 14Aneutralmateriality 6/10

20-03-2026

X4 Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on March 20, 2026, for the virtual 2026 Annual Meeting of Stockholders on May 11, 2026, at 12:00 p.m. ET. Key proposals include electing three Class III directors to serve until the 2029 annual meeting, ratifying PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026, approving the Second Amended and Restated 2017 Equity Incentive Plan to increase available shares, and a non-binding advisory vote on named executive officer compensation. The record date is March 13, 2026.

  • ·Annual Meeting held virtually via live audio-only webcast at www.virtualshareholdermeeting.com/XFOR2026.
  • ·Company address: 61 North Beacon Street, 4th Floor, Boston, Massachusetts 02134.
  • ·Proxy materials available at www.proxyvote.com.
HERITAGE FINANCIAL CORP /WA/DEF 14Amixedmateriality 8/10

20-03-2026

Heritage Financial Corporation reported strong 2025 profitability with net income up 56.1% YoY to $67.5 million and diluted EPS rising 58.1% to $1.96, alongside deposit growth of 4.1% to $5.92 billion and dividends increasing 4.3% to $0.96 per share. However, total assets declined 2.0% to $6.97 billion, net loans fell slightly 0.4% to $4.73 billion, and overhead ratio worsened 6.3% to 2.36%, impacted by $10.7 million in pre-tax losses from securities sales and $1.0 million in merger costs with Olympic Bancorp (effective January 31, 2026). The proxy statement solicits votes for electing 11 directors, advisory approval of executive compensation, and ratification of Crowe LLP as auditors at the virtual annual meeting on May 7, 2026.

  • ·Record date for shareholders: March 9, 2026
  • ·Board composition: average age 61 years, 55% diversity (4 gender, 2 ethnic), average tenure 11 years, 91% independent (10 of 11 directors)
  • ·Virtual meeting access: www.meetnow.global/MYZUC44
Invesco Mortgage Capital Inc.DEF 14Aneutralmateriality 6/10

20-03-2026

Invesco Mortgage Capital Inc. filed its 2026 Proxy Statement for the Annual Meeting, seeking stockholder approval for the election of six director nominees (Robert L. Fleshman, Katharine W. Kelley, Stephanie J. Larosiliere, Don H. Liu, W. Wesley McMullan, and Robert B. Waldner) to serve until the 2027 Annual Meeting, following the planned reduction of the Board from eight to seven members due to Carolyn Gibbs' retirement on March 31, 2026, and Carolyn Handlon not seeking re-election. Additional proposals include an advisory vote to approve executive compensation and ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026, with the Board unanimously recommending a FOR vote on all items. No financial performance metrics are disclosed in the filing.

  • ·Don H. Liu appointed Board Chair on November 4, 2025.
  • ·Robert L. Fleshman appointed director on November 8, 2024, and Audit Committee Chair effective January 1, 2026.
  • ·Director election requires majority of votes cast; incumbent nominees not elected must submit resignation for Board consideration.
  • ·Filing references Annual Report on Form 10-K for year ended December 31, 2025.
COHEN & STEERS, INC.DEF 14Aneutralmateriality 6/10

20-03-2026

Cohen & Steers, Inc. filed its DEF 14A proxy statement dated March 20, 2026, for the virtual 2026 Annual Meeting of Shareholders on April 30, 2026, at 9:00 a.m. New York time. Shareholders will vote on electing nine director nominees, ratifying Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and a non-binding advisory vote to approve named executive officer compensation. The record date is March 5, 2026, with 51,393,909 shares of common stock outstanding.

  • ·Annual Meeting held virtually via live audio webcast at http://www.virtualshareholdermeeting.com/CNS2026; requires 16-digit Control Number to participate.
  • ·Proxy materials furnished primarily via Internet under SEC Notice and Access rules; available at www.proxyvote.com and https://materials.proxyvote.com/19247A.
  • ·Board recommends voting FOR all three proposals.
YORK WATER CODEF 14Aneutralmateriality 5/10

20-03-2026

The York Water Company (YORW) filed its definitive proxy statement (DEF 14A) on March 20, 2026, with a conformed period of report ending March 13, 2026. The filing provides standard company details including its Pennsylvania incorporation, fiscal year end of December 31, EIN 23-1242500, and SIC code 4941 for water supply. No financial metrics, period-over-period comparisons, executive compensation, or voting items are discernible from the available content, which primarily consists of metadata and encoded graphics.

  • ·Filing Date: March 20, 2026
  • ·Conformed Period of Report: March 13, 2026
  • ·Fiscal Year End: December 31
  • ·EIN: 23-1242500
  • ·SIC: 4941 (Water Supply)
  • ·Business Address: 130 E Market St, York, PA 17401-1219
  • ·Business Phone: 717-845-3601
  • ·State of Incorporation: PA
  • ·SEC File Number: 001-34245
CNA FINANCIAL CORPDEF 14Aneutralmateriality 6/10

20-03-2026

CNA Financial Corporation's definitive proxy statement for its 2026 Annual Meeting on April 29, 2026, solicits votes for electing 10 Board nominees (following Dino E. Robusto's resignation on December 31, 2025, fixing Board size at 10), an advisory vote approving named executive officer compensation, amending the Incentive Compensation Plan to authorize an additional 5,000,000 shares, and ratifying Deloitte & Touche LLP as 2026 independent auditors. The record date is March 6, 2026, with 269,918,371 shares of Common Stock outstanding. The Board recommends FOR all proposals, with no reported controversies or declines noted.

  • ·Annual Meeting location: 151 N. Franklin Street, 7th Floor Navy Pier 3 Room, Chicago, Illinois 60606 at 7:30 a.m. Central time.
  • ·Voting methods: Internet (www.proxyvote.com), phone (1-800-690-6903), or mail to Broadridge.
  • ·Proxy materials and 2025 Annual Report available at www.cna.com.
MGIC INVESTMENT CORPDEF 14Apositivemateriality 7/10

20-03-2026

MGIC Investment Corporation's 2026 Proxy Statement for the April 23, 2026 annual shareholder meeting seeks approval for electing ten directors, an advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors. The filing highlights strong 2025 performance including $61.9B in New Insurance Written, $303.1B Insurance In Force, 13.5% Return on Equity, and +42% growth in Adjusted Book Value Per Share amid challenging market conditions with high interest rates and rising home prices.

  • ·Annual meeting scheduled for April 23, 2026 at 9:00 a.m. Central Time via webcast at www.virtualshareholdermeeting.com/MTG2026
  • ·Proposals include election of ten directors, advisory vote to approve NEO compensation, and ratification of PwC as 2026 independent auditors
Huron Consulting Group Inc.DEF 14Amixedmateriality 8/10

20-03-2026

Huron Consulting Group's 2026 Proxy Statement discloses 2025 executive compensation, with CEO C. Mark Hussey's total pay rising 10% YoY to $7.2M on higher salary ($1.02M) and stock awards ($4.6M), though non-equity incentive compensation dipped 2% to $1.52M; CFO John D. Kelly's total increased 5% to $3.1M while COO J. Ronald Dail's fell 2% to $2.4M. Annual incentives paid out at 102% of target based on financial and strategic goals. New grants include PSUs and RSUs under the 2012 Omnibus Incentive Plan, with prohibitions on hedging and pledging of company stock.

  • ·Prohibited hedging, pledging, margin accounts under insider trading policy.
  • ·PSUs for 2025-2027 cycle vest March 1, 2028; max grant values: CEO $6.5M, CFO $2.3M.
  • ·Section 280G excess parachute payments reduced to avoid 20% excise tax.
  • ·2024 10-K filed February 25, 2025.

Get daily alerts with 12 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 50 filings

🇺🇸 More from United States

View all →